Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

Overview of attention for article published in BMC Neurology, November 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 6 tweeters

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 7 tweets from 6 users, with an upper bound of 1,631 followers.

11-16-2021: Actemra (tocilizumab) performed extremely well for treating neuromyelitis optica spectrum disorders https://t.co/9cYz565kTb https://t.co/03bw6OPdp4 https://t.co/GimLkHnr9a https://t.co/cUbUkiF07Y https://t.co/cQhmoXnrpQ https://t.co/8QBx7jhZRE

15 Aug 2022

Reply Retweet Favourite

New NNT→Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis https://t.co/Ti8i36VZo1

30 Nov 2021

Reply Retweet Favourite

RT @kharel560182: We are pleased to share our article "Safety and efficacy of interleukin-6-receptor inhibitors in treatment of neuromyelit…

25 Nov 2021

Reply Retweet Favourite

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis https://t.co/GGKXwLf9hf

24 Nov 2021

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 3 additional tweets.